Tripos To Restate Prior-Year Results

Following on the heels of similar announcements from informatics firms Accelrys and Lion Biosciences [BioInform 02-09-04], Tripos last week said that it plans to revise the way it recognizes revenue for its software licenses.

Due to the revised policy, the company said it will have to restate its financial results for prior fiscal years.

Tripos also postponed the release of its 2003 fourth-quarter and year-end earnings, which were scheduled for release on Feb. 12.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.